AAVAA [AH-vah] Therapeutics is
a first-of-its-kind company championing
AAV-based gene therapies for the treatment,
and cure, of skeletal diseases.
Novel Treatment Options for
You shouldn’t have to settle for less than the quality of life you deserve. AAVAA Therapeutics is the first gene therapy company to target debilitating and life-threatening skeletal diseases.
AAV-based Gene Therapy
There are no such things as incurable. It’s only a matter of finding a cure. We believe AAV gene therapy will carry us there. Our single-injection AAV gene therapy will deliver life-long curative treatments for such skeletal diseases as osteoarthritis, osteoporotic fractures and rare bone diseases.
World-class Gene Therapy Champions
AAVAA Therapeutics is spearheading translational research & development efforts in AAV gene therapies for skeletal diseases with state-of-the-art medical institutions worldwide.